RegenexBio ^Company

REGENXBIO, a leader in AAV gene therapy. This cell therapy companies is seeking to change the way diseases are treated, REGENXBIO is developing gene therapies in treating retinal, metabolic, and neurodegenerative diseases. Their pipeline includes a wide range of issues, such as diabetic retinopathy, HoFH, and MPS II.